Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMGP.L Regulatory News (MGP)

  • There is currently no data for MGP

Post-Close Trading Update

24 Jan 2019 07:00

RNS Number : 9311N
Medica Group PLC
24 January 2019
 

24 January 2019

Medica Group Plc

 

Post-Close Trading Update

 

Medica Group Plc (LSE: MGP, "Medica" or the "Company"), the UK market leader in the provision of teleradiology services, announces a post-close period trading update for the year ended 31 December 2018.

 

The Company has achieved revenue for the year of £39.0m, an increase of 15.6% year on year, driven by increased demand for NightHawk and Cross-Sectional services, in line with the Company's strategy. The Company also expects to maintain the EBITDA margin of around 30% as seen at the H1 report. The Board expects the Company's performance for 2018 to be in line with market expectations.

 

The total number of contracted radiologists (including radiographers and rheumatologists) as at 31 December 2018 was 362 radiologists (31 December 2017: 306).

 

John Graham, Chief Executive Officer of Medica, commented:

 

"In 2018, Medica continued to deliver double-digit revenue growth as we execute our strategy to increase customer penetration of our NightHawk and Cross Sectional services. Additionally, during 2018 we continued to generate cash and had zero net debt at the year-end.

 

The combination of our market leading platform, strong cohort of radiologists and our reputation for high quality clinical governance means that Medica is well positioned to help our customers meet their requirements for teleradiology services.

 

In 2019 we expect that the business will continue to grow at a similar rate to that seen in 2018 giving us confidence to increase investment to support future growth opportunities."

 

Medica will publish final statutory results for the year ended 31 December 2018 on 25 March 2019.

 

-ENDS-

 

For further details contact:

 

Medica Group:

+44 (0)33 33 111 222

John Graham, Chief Executive Officer

Tony Lee, Chief Financial Officer

FTI Consulting

+44 (0)20 3727 1000

Brett Pollard

Ben Atwell

Robert Winder

 

 

About Medica

 

Medica is the UK market leader by revenue in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI (magnetic resonance imaging), CT (computerised tomography) and plain film (x-ray) images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional (Routine CS) reporting on MRI and CT scans, and routine plain film (Routine PF) reporting on x-ray images.

 

Medica has developed a bespoke secure IT platform that provides market-leading linkage between a hospital's Radiology Information System (RIS) and Consultant Radiologists who contract with Medica. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

 

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies. For more information please visit www.medicagroup.co.uk

 

About teleradiology

 

Teleradiology is the electronic transmission of radiological patient images, including plain film (x-rays), CT scans and MRI scans, from one location to another for the purposes of diagnostic interpretation and reporting.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUORBRKUAAUAR
Date   Source Headline
27th Apr 202311:34 amRNSForm 8.3 - Medica Group Plc
27th Apr 202311:34 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
27th Apr 202311:32 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc Amended
27th Apr 202311:29 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc Amended
27th Apr 202310:39 amRNSForm 8.3 - Medica Group Plc
27th Apr 202310:05 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
27th Apr 20239:17 amRNSForm 8.3 - Medica Group PLC
27th Apr 20239:16 amRNSForm 8.3 - Medica Group PLC
27th Apr 20239:12 amRNSForm 8.3 - Medica Group plc
27th Apr 20238:45 amRNSForm 8.3 - Medica Group Plc
26th Apr 202311:46 amGNWRule 8.3 - Medica Group Plc
26th Apr 20239:47 amRNSForm 8.3 - Medica Group PLC
26th Apr 20239:14 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
25th Apr 20233:20 pmRNSForm 8.3 - Medica Group plc
25th Apr 20232:43 pmRNSForm 8.3 - Medica Group plc
25th Apr 20232:43 pmRNSForm 8.3 - MEDICA GROUP PLC
25th Apr 202312:05 pmRNSForm 8.3 - Medica Group plc
25th Apr 202311:55 amRNSForm 8.3 - Medica Group plc
25th Apr 202311:54 amRNSForm 8.3 - Medica Group PLC
25th Apr 202311:52 amRNSForm 8.3 - Medica Group PLC
25th Apr 202311:30 amRNSForm 8.3 - Medica Group PLC
25th Apr 20239:49 amRNSForm 8.5 (EPT/RI) - Medica Group PLC
25th Apr 20239:45 amRNSForm 8.5 (EPT/NON-RI) Medica Group Plc
24th Apr 20232:42 pmRNSForm 8.3 - Medica Group plc
24th Apr 20237:00 amRNSRECOMMENDED CASH ACQUISITION OF MEDICA GROUP PLC
29th Mar 20237:00 amRNSResults for the year ended 31 December 2022
22nd Mar 20237:00 amRNSNotice of Results
14th Mar 202311:39 amRNSHolding(s) in Company
13th Mar 202312:22 pmRNSHolding(s) in Company
13th Mar 20237:00 amRNSStatement regarding Silicon Valley Bank
23rd Feb 202312:23 pmRNSHolding(s) in Company
22nd Feb 20234:42 pmRNSHolding(s) in Company
17th Jan 20237:00 amRNSTrading update for FY22 and outlook for FY23
12th Jan 202311:15 amRNSDirector Declaration
9th Jan 20232:38 pmRNSHolding(s) in Company
4th Jan 20231:42 pmRNSIssue of Equity, Block Listing Six Monthly Return
2nd Dec 20222:48 pmRNSHolding(s) in Company
11th Nov 20221:28 pmRNSHolding(s) in Company
10th Nov 20222:09 pmRNSDirector/PDMR Shareholding
8th Nov 20221:35 pmRNSHolding(s) in Company
8th Nov 20221:25 pmRNSDirector/PDMR Shareholding
8th Nov 20221:24 pmRNSDirector/PDMR Shareholding
2nd Nov 20221:49 pmRNSHolding(s) in Company
31st Oct 202212:06 pmRNSHolding(s) in Company
21st Oct 20223:26 pmRNSDirector/PDMR Shareholding
5th Oct 20221:47 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
13th Sep 20224:41 pmRNSSecond Price Monitoring Extn
13th Sep 20224:37 pmRNSPrice Monitoring Extension
31st Aug 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.